Hoth Therapeutics Inc

Research Hoth Therapeutics Inc (HOTH) on Bullrun: market cap USD 20.66M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHOTH
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 20.66M
• Financial periodFY2025
• Net income-USD 12.47M

Valuation Snapshot

latest market cap is USD 20.66M.

About Hoth Therapeutics Inc

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke;

Frequently asked questions

What is Hoth Therapeutics Inc's market cap?

Hoth Therapeutics Inc's market capitalization is USD 20.66M.

What does Hoth Therapeutics Inc do?

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States.